CVS Health, in an announcement accompanied by preliminary third-quarter financials, reported it appointed David Joyner president and CEO, replacing Karen Lynch, who stepped down from her position in agreement with the company’s board of directors. Joyner also...
CVS Health beat an analyst consensus estimate on second-quarter earnings, but fell short on revenue as front-store sales slipped. CVS’ net income was $1.77 billion, or $1.41 per diluted share, versus $1.9 billion, or $1.48 per diluted share, in the year-earlier...
The third quarter saw CVS Health financials beat Wall Street estimates on income and sales as it turned in better sales and almost flat adjusted earnings year over year. The company posted a net income of $2.26 million, or $1.75 per diluted share, versus a net loss of...
In the second quarter, CVS Health topped analyst estimates although front end comparable sales slipped slightly after a 10% gain in the 2022 period. Company net income was $1.9 billion, or $1.48 per diluted share, versus $3.03 billion, or $2.29 per diluted share, in...
In the midst of reorganizing the company, CVS Health posted lower net income that was still good enough to beat a Wall Street estimate, and it recorded a front-end comp gain. Company net income was $2.14 billion, or $1.65 per diluted share, versus $2.35 billion, or...
